PETALING JAYA: DXN Holdings Bhd
saw its net profit for the third quarter ended Nov 30, 2025, dip to RM64.76mil from RM92.78mil in the previous corresponding period, while revenue dropped to RM463.30mil from RM486.09mil a year earlier.
In a filing with Bursa Malaysia, the health food supplements firm said the decline was mainly due to unfavourable currency translation effects arising from the depreciation of foreign currencies against the ringgit.
“Excluding currency translation effects, revenue performance in local currencies remained positive, supported by growth in Peru, India and Bolivia, which recorded growth rates ranging from 4.8% to 39%.
“Revenue from the Middle East declined due to softer demand, as members made advance purchases ahead of price revision in September 2025.”
For the nine-month period ended Nov 30, 2025, DXN’s net profit slipped to RM208.93mil from RM244.31mil in the previous corresponding period, while revenue stood at RM1.42bil compared with RM1.45bil previously.
The company declared a third interim dividend of 0.8 sen per ordinary share, totalling RM39.78mil for the financial year ending Feb 28, 2026, which will be paid on Feb 27, 2026.
